The Influence of Connective Tissue Disease in Breast Reconstruction: A National Database Analysis.

Authors:
Austin D Chen
Austin D Chen
Beth Israel Deaconess Medical Center
Boston | United States
David Chi
David Chi
East Tennessee State University
United States
Alexandra Bucknor
Alexandra Bucknor
Guy's Hospital
Bernard T Lee
Bernard T Lee
Harvard Medical School
Israel
Samuel J Lin
Samuel J Lin
Harvard Medical School
Israel

Ann Plast Surg 2018 Apr;80(4 Suppl 4):S182-S188

From the Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Background: Patients with connective tissue diseases (CTD), or collagen vascular diseases, are at risk of potentially higher morbidity after surgical procedures. We aimed to investigate the complication profile in CTD versus non-CTD patients who underwent breast reconstruction on a national scale.

Methods: A retrospective analysis of the Healthcare Cost and Utilization Project NIS Database between 2010 and 2014 was conducted for patients 18 years or older admitted for immediate autologous or implant breast reconstruction. Connective tissue disease was defined as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, scleroderma, Raynaud phenomenon, psoriatic arthritis, or sarcoidosis. Independent t test/Wilcoxon-Mann-Whitney was used to compare continuous variables and Pearson χ/Fischer exact test was used for categorical variables. Outcomes of interest were assessed using multivariable linear regressions for continuous variables and multivariable logistic regressions for categorical variables.

Results: There were 19,496 immediate autologous breast reconstruction patients, with 357 CTD and 19,139 non-CTD patients (2010-2014). The CTD patients had higher postoperative complication rates for infection (2.8% vs 0.8%, P < 0.001), wound dehiscence (1.4% vs 0.4%, P = 0.019), and bleeding (hemorrhage and hematoma) (6.7% vs 3.5%, P < 0.001). After multivariable analysis, CTD remained an independent risk factor for bleeding (odds ratio [OR], 1.568; 95% confidence interval [CI], 1.019-2.412). There were a total of 23,048 immediate implant breast reconstruction patients, with 431 CTD and 22,617 non-CTD patients (2010-2014). The CTD patients had a higher postoperative complication rate for wound dehiscence/complication (2.3% vs 0.6%, P < 0.001). They also experienced a longer length of stay (2.31 days vs 2.07 days, P < 0.001). After multivariable analysis, CTD remained an independent risk factor for wound dehiscence (OR, 4.084; 95% CI, 2.101-7.939) and increased length of stay by 0.050 days (95% CI, -0.081 to 0.181).

Conclusions: Connective tissue disease patients who underwent autologous breast reconstruction had significantly higher infection, wound dehiscence, and bleeding rates, and those who underwent implant breast reconstruction had significantly higher wound dehiscence rates. Connective tissue diseases appear to be an independent risk factor for bleeding and wound dehiscence in autologous and implant breast reconstruction, respectively. This information may help clinicians be aware of this increased risk when determining patients for reconstruction.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SAP.0000000000001387DOI Listing
April 2018
4 Reads

Publication Analysis

Top Keywords

breast reconstruction
32
connective tissue
20
wound dehiscence
20
implant breast
16
independent risk
12
non-ctd patients
12
risk factor
12
tissue disease
12
patients
11
reconstruction
9
ctd
8
patients higher
8
higher postoperative
8
postoperative complication
8
ctd patients
8
autologous breast
8
reconstruction higher
8
continuous variables
8
autologous implant
8
tissue diseases
8

Altmetric Statistics

Similar Publications

Impact of Connective Tissue Disease on Oncologic Breast Surgery and Reconstruction.

Ann Plast Surg 2016 Jun;76(6):635-9

From the Department of Plastic Surgery, Georgetown University Hospital, Washington, DC.

Background: The impact of connective tissue disease (CTD) on outcomes following breast surgery and reconstruction is unknown. The purpose of this study was to evaluate the effect of both CTDs and systemic immunomodulatory therapy on outcomes following breast surgery and reconstruction.

Methods: A retrospective review was performed of all patients from 2005 to 2010 with an active CTD who underwent breast surgery with or without reconstruction. Read More

View Article
June 2016

Breast reconstruction in the high risk patient with systemic connective tissue disease: a case series.

J Plast Reconstr Aesthet Surg 2013 Jan 5;66(1):61-6. Epub 2012 Aug 5.

Burns and Plastic Surgery, Canniesburn Unit, Glasgow Royal Infirmary, Glasgow G4 0SF, UK.

Introduction: The presence of severe underlying connective tissue disease may restrict the reconstructive options offered to a woman in the event of mastectomy. Putative concerns about reconstructive surgery include the effects of connective tissue disease and immunosuppression on wound healing and donor site morbidity, and increased risks of deranged clotting and thrombophilia after free tissue transfer. There is also the possibility of an unpredictable tissue reaction after oncological resection surgery and adjuvant radiotherapy. Read More

View Article
January 2013

Predictors of readmission after breast reconstruction: a multi-institutional analysis of 5012 patients.

Ann Plast Surg 2013 Oct;71(4):335-41

From the *Division of Plastic and Reconstructive Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL; †Department of Plastic Surgery, University of Tennessee Health Science Center, Memphis, TN; and ‡Rosalind Franklin University of Medicine and Science, Chicago Medical School, North Chicago, IL.

Background: Recent health care legislation institutes penalties for surgical readmissions secondary to complications. There is a paucity of evidence describing risk factors for readmission after breast reconstruction procedures.

Methods: Patients undergoing breast reconstruction in 2011 were identified in the National Surgical Quality Improvement Program database. Read More

View Article
October 2013

A Nationwide Analysis of Cost Variation for Autologous Free Flap Breast Reconstruction.

JAMA Surg 2017 Nov;152(11):1039-1047

Section of Plastic Surgery, University of Michigan Health System, Ann Arbor.

Importance: Cost variation among hospitals has been demonstrated for surgical procedures. Uncovering these differences has helped guide measures taken to reduce health care spending. To date, the fiscal consequence of hospital variation for autologous free flap breast reconstruction is unknown. Read More

View Article
November 2017